Paper69269
Short-term antithyroid drug therapy for the thyrotoxicosis of Graves's disease.
Greer MA and 2 others. N Engl J Med, 1977. Cited by 69 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Short-term antithyroid drug therapy for the thyrotoxicosis of Graves's disease. Papers, record 69269. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/69269
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antithyroid Agents | Major topic |
| Graves Disease | Major topic |
| Administration, Oral | |
| Adolescent | |
| Adult | |
| Child | |
| Female | |
| Humans | |
| Male | |
| Methimazole | |
| Middle Aged | |
| Prognosis | |
| Propylthiouracil | |
| Remission, Spontaneous | |
| Thyroidectomy | |
| Thyroxine | |
| Time Factors | |
| Triiodothyronine |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 69 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39,407,446 | Long-Term Antithyroid Drug Therapy in Smoldering or Fluctuating-Type Graves' Hyperthyroidism with Potassium Iodide. | Endocrinol Metab (Seoul) | 2024 | https://conductscience.org/library/papers/39407446 | PubMed |
| 35,088,381 | Appropriate duration of antithyroid drug treatment as a predictor for relapse of Graves' disease: a systematic scoping review. | J Endocrinol Invest | 2022 | https://conductscience.org/library/papers/35088381 | PubMed |
| 25,089,127 | Pediatric Graves' disease: management in the post-propylthiouracil Era. | Int J Pediatr Endocrinol | 2014 | https://conductscience.org/library/papers/25089127 | PubMed |
| 7,560,811 | Simple and reliable method for predicting the remission of Graves' disease: revised triiodothyronine-suppression test, indexed by serum thyroxine. | J Endocrinol Invest | 1995 | https://conductscience.org/library/papers/7560811 | PubMed |
| 7,376,643 | Single daily dose methimazole treatment of hyperthyroidism. | West J Med | 1980 | https://conductscience.org/library/papers/7376643 | PubMed |
| 6,199,072 | Are antithyroid drugs immunosuppressive? | Br Med J (Clin Res Ed) | 1984 | https://conductscience.org/library/papers/6199072 | PubMed |
| 6,172,233 | Clinical pharmacokinetics of antithyroid drugs. | Clin Pharmacokinet | 1981 | https://conductscience.org/library/papers/6172233 | PubMed |
| 3,840,555 | [Indications for conservative and operative therapy of thyroid autonomy and Basedow hyperthyroidism from the internal medicine viewpoint]. | Langenbecks Arch Chir | 1985 | https://conductscience.org/library/papers/3840555 | PubMed |
| 3,302,147 | Stopping and restarting medications in the perioperative period. | J Gen Intern Med | 1987 | https://conductscience.org/library/papers/3302147 | PubMed |
| 2,892,877 | Thyroid stimulating immunoglobulin bioactivity during carbimazole therapy as measured by the cytochemical bioassay. | J Endocrinol Invest | 1987 | https://conductscience.org/library/papers/2892877 | PubMed |
| 2,573,625 | Thyroglobulin, thyrotropin and thyrotropin binding inhibiting immunoglobulins assayed at the withdrawal of antithyroid drug therapy as predictors of relapse of Graves' disease within one year. | J Endocrinol Invest | 1989 | https://conductscience.org/library/papers/2573625 | PubMed |
| 2,564,286 | Optimum duration of antithyroid drug treatment determined by assay of thyroid stimulating antibody in patients with Graves' disease. | BMJ | 1989 | https://conductscience.org/library/papers/2564286 | PubMed |
| 2,038,087 | Remission of Graves' disease with hyperthyroidism by a combination of glucocorticoids and antithyroid drugs. | J Natl Med Assoc | 1991 | https://conductscience.org/library/papers/2038087 | PubMed |
| 1,478,841 | Management of patients with diffuse toxic goitre in Ireland, a country with low iodine intake. | Ir J Med Sci | 1992 | https://conductscience.org/library/papers/1478841 | PubMed |
| 1,283,984 | Antithyroid drug and Graves' hyperthyroidism. Significance of treatment duration and TRAb determination on lasting remission. | J Endocrinol Invest | 1992 | https://conductscience.org/library/papers/1283984 | PubMed |
| 90,689 | Determination of thyroid stimulating immunoglobulins (TSI) during the course of Graves' disease. A reliable indicator for remission and persistence of this disease? | J Endocrinol Invest | 1978 | https://conductscience.org/library/papers/90689 | PubMed |
| 77,148 | Selection of treatment in the management of thyrotoxicosis in childhood and adolescence. | Ann Surg | 1978 | https://conductscience.org/library/papers/77148 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/69269
GET https://conductscience.org/api/papers/v1/69269/authors